Sherbrooke Park Advisers’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,921	Closed	-$399K	–	824
2024 Q4	$399K	Sell	2,921 -2,389	-45%	-$326K	0.13%	288
2024 Q3	$612K	Sell	5,310 -2,899	-35%	-$334K	0.14%	236
2024 Q2	$1.13M	Buy	+8,209	New	+$1.13M	0.2%	148